Skopos Labs, Inc. Emergent Bio Solutions Inc. Transaction History
Skopos Labs, Inc.
- $497 Million
- Q2 2025
A detailed history of Skopos Labs, Inc. transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Skopos Labs, Inc. holds 4,164 shares of EBS stock, worth $43,680. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,164
Previous 4,164
-0.0%
Holding current value
$43,680
Previous $20,000
30.0%
% of portfolio
0.01%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding EBS
# of Institutions
193Shares Held
39.5MCall Options Held
390KPut Options Held
157K-
Black Rock Inc. New York, NY3.84MShares$40.3 Million0.0% of portfolio
-
Oak Hill Advisors LP New York, NY3.61MShares$37.9 Million2.74% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.58MShares$37.6 Million0.0% of portfolio
-
American Century Companies Inc Kansas City, MO2.29MShares$24 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.85MShares$19.4 Million0.0% of portfolio
About Emergent BioSolutions Inc.
- Ticker EBS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,861,500
- Market Cap $523M
- Description
- Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...